Ontology highlight
ABSTRACT:
SUBMITTER: Nonomiya Y
PROVIDER: S-EPMC5198950 | biostudies-literature | 2016 Dec
REPOSITORIES: biostudies-literature
Nonomiya Yuma Y Noguchi Kohji K Tanaka Noritaka N Kasagaki Takahiro T Katayama Kazuhiro K Sugimoto Yoshikazu Y
Cancer science 20161219 12
Polo-like kinase (PLK) is a cell-cycle regulator that is overexpressed in several cancer cell types. Polo-like kinase is considered a novel target for cancer therapies, and several PLK inhibitors (PLKis), including BI 2536, BI 6727, and GSK461364, have been developed. In this study, we established five BI 2536-resistant cell lines from human colorectal cancer HCT 116 cells, to explore the resistance mechanism and identify predictable biomarkers of PLKis. We showed that PLKi-induced caspase-8 act ...[more]